References and Further Reading
Ali, A., Black, D., & Soslow, R. A. (2007). Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. International Journal of Gynecological Pathology, 26, 115–123.
Ashman, J. B., Connell, P. P., Yamanda, D., et al. (2001). Outcome of endometrial carcinoma patients with involvement of the uterine serosa. Gynecologic Oncology, 82, 338.
Baak, J. P., Mutter, G. L., Robboy, S., et al. (2005a). The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer, 103, 2304–2312.
Baak, J. P. A., van Diermen, B., Steinbakk, A., et al. (2005b). Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression. Human Pathology, 36, 555–561.
Bakhsh, S., Kinloch, M., Hoang, L. N., et al. (2016). Histopathological features of endometrial carcinomas associated with POLE mutations: Implications for decisions about adjuvant therapy. Histopathology, 68, 916–924.
Battle, B. A., Bruegl, A. S., Daniels, M. S., et al. (2014). Consequences of universal MSI/IHC in screening endometrial cancer patients for Lynch syndrome. Gynecologic Oncology, 134(2), 319–325.
Bokhman, J. V. (1983). Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology, 15(1), 10–17. https://doi.org/10.1016/0090-8258(83)90111-7.
Bosse, T., Nout, R. A., McAlpine, J. N., et al. (2018). Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups. The American Journal of Surgical Pathology, 42, 561–568.
Buza, N., Ziai, J., & Hui, P. (2016). Mismatch repair deficiency testing in clinical practice. Expert Review of Molecular Diagnostics, 16(5), 591–604.
Cancer Genome Atlas Research Network, Kandoth, C., Schultz, N., Cherniack, A. D., et al. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497, 67–73.
Chan, J. K., Kapp, D. S., Cheung, M. K., et al. (2007). The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients. British Journal of Cancer, 97, 606–611.
Checmareva, M., Ellenson, L. H., & Pirog, E. C. (2008). Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium. International Journal of Gynecological Pathology, 27, 547–554.
Chi, D. S., Barakat, R. R., Palayekar, M. J., et al. (2008). The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. International Journal of Gynecological Cancer, 18, 269–273.
Clement, P. B., & Young, R. H. (2002). Endometrioid carcinoma of the uterine corpus: A review of its pathology with emphasis on recent advances and problematic aspects. Advances in Anatomic Pathology, 9(3), 145–184.
Conlon, N., Leitao, M. M., Jr., Abu Rustum, N. R., et al. (2014). Grading uterine endometrioid carcinoma: A proposal that binary is best. The American Journal of Surgical Pathology, 38, 1583–1587.
Connell, P. P., Rotmensch, J., Waggoner, S., et al. (1999). The significance of adnexal involvement in endometrial carcinoma. Gynecologic Oncology, 74, 74–79.
Diaz-Padilla, I., Romero, N., Amir, E., et al. (2013). Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology, 88(1), 154–167.
Eichhorn, J. H., Young, R. H., & Clement, P. B. (1996). Sertoliform endometrioid adenocarcinoma. A study of four cases. International Journal of Gynecological Pathology, 15, 119–126.
Fujiwara, M., & Longacre, T. A. (2011). Low-grade mucinous adenocarcinomas of the uterine corpus: A rare and deceptively bland form of endometrial carcinoma. The American Journal of Surgical Pathology, 35, 537–544.
Garg, K., & Soslow, R. A. (2012). Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium. Advances in Anatomic Pathology, 19, 1–10.
Garg, G., Gao, F., Wright, J. D., et al. (2013). Positive peritoneal cytology in an independent risk factor in early stage endometrial cancer. Gynecologic Oncology, 128, 77–82.
Gilks, C. B., Oliva, E., & Soslow, R. A. (2013). Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma. The American Journal of Surgical Pathology, 37, 874–881.
Hakima, L., Ogden, I., Feuerman, M., et al. (2012). Lower uterine segment involvement in low grade endometrioid endometrial adenocarcinoma: A predictor of disease progression and survival. [Abstract] Modern Pathology, 25, 275A.
Hanley, K. Z., Dustin, S. M., Stoler, M. H., et al. (2010). The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma. International Journal of Gynecological Pathology, 29, 445–451.
Hong, W., Abi-Raad, R., Alomari, A. K., Hui, P., & Buza, N. (2015). Diagnostic application of KRAS mutation testing in uterine microglandular proliferations. Human Pathology, 46(7), 1000–1005.
Hussein, Y. R., Hayek, K., Bandyopadhyay, S., et al. (2012). Mucinous carcinoma of the endometrium: Multi-institutional clinicopathologic study of a series of 47 patients. [Abstract] Modern Pathology, 25, 277A.
Hussein, Y. R., Weigelt, B., Levine, D. A., et al. (2015). Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations. Modern Pathology, 28, 505–514.
Hussein, Y. R., Broaddus, R., Weigelt, B., et al. (2016). The genomic heterogeneity of FIGO 3 endometrioid carcinoma impacts diagnostic accuracy and reproducibility. International Journal of Gynecological Pathology, 35, 16–24.
Ismil, N., Rasty, G., Ghorab, Z., et al. (2007). Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion. Annals of Diagnostic Pathology, 11, 252–257.
Kapucuoglu, N., Bulbul, D., Tulunay, G., et al. (2008). Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters. International Journal of Gynecological Cancer, 18, 790–796.
Kurman, R. J., & Norris, H. J. (1982). Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer, 49, 2547–2559.
Kurman, R. J., Kaminski, P. E., & Norris, H. J. (1985). The behavior of endometrial hyperplasia. A long-term study of ‘untreated’ hyperplasia in 170 patients. Cancer, 56, 403–412.
Lynch, H. T., Shaw, M. W., Magnuson, C. W., Larsen, A. L., & Krush, A. J. (1966). Hereditary factors in cancer. Study of two large midwestern kindreds. Archives of Internal Medicine, 117(2), 206–212.
McKenney, J. K., & Longacre, T. A. (2009). Low-grade endometrial adenocarcinoma. A diagnostic algorithm of distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics. The American Journal of Surgical Pathology, 16, 1–22.
Mills, A. M., Liou, S., Ford, J. M., Berek, J. S., Pai, R. K., & Longacre, T. A. (2014). Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. The American Journal of Surgical Pathology, 38(11), 1501–1509.
Murray, S. K., Young, R. H., & Scully, R. E. (2000). Uterine Endometrioid carcinoma with small nonvillous papillae: An analysis of 26 cases of a favorable-prognosis tumor to be distinguished from serous carcinoma. International Journal of Surgical Pathology, 8(4), 279–289.
Murray, S. K., Clement, P. R., & Young, R. H. (2005). Endometrioid carcinoma of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: A report of 31 cases of a neoplasm that may be confused with carcionsarcoma and other uterine neoplasms. The American Journal of Surgical Pathology, 29(2), 157–166.
Norris, H. J., Tavassoli, F. A., & Kurman, R. J. (1983). Endometrial hyperplasia and carcinoma. Diagnostic considerations. The American Journal of Surgical Pathology, 7, 839–847.
Quick, C. M., Laury, A. R., Monte, N. M., et al. (2012). Utility of PAX2 is a marker for diagnosis of endometrial intraepithelial carcinoma. American Journal of Clinical Pathology, 138, 678–684.
Rakha, E., Wong, S. C., Soomro, I., et al. (2012). Clinical outcome pf atypical endometrial hyperplasia diagnosed on an endometrial biopsy. The American Journal of Surgical Pathology, 36, 1683–1690.
Shia, J., Black, D., Hummer, A. J., et al. (2008). Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. Human Pathology, 39, 116–125.
Silva, E. G., Deavers, M. T., Bodurka, D. C., et al. (2006). Association of low-grade endometrioid of the uterus and ovary with undifferentiated carcinoma: A new type of dedifferentiated carcinoma? International Journal of Gynecological Pathology, 25, 52–58.
Stefanson, I. M., Salvesen, H. B., Immervoll, H., et al. (2004). Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Histopathology, 44, 472–479.
Tambouret, R., Clement, P. B., & Young, R. H. (2003). Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: A manifestation of stage IIb endometrioid carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion. The American Journal of Surgical Pathology, 27(8), 1080–1088.
Trimble, C. L., Kauderer, J., Zaino, R., et al. (2006). Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia. Cancer, 106, 812–819.
Young, R. H., & Scully, R. E. (1992). Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. The American Journal of Surgical Pathology, 16(11), 1092–1097.
Zaino, R. J., Kurman, R. J., Diana, K. L., et al. (1995). The utility of the revised International Federation of Gynecology and Oncology histologic grading of endometrial endometrioid carcinoma using a defined nuclear grading system. Cancer, 75, 81–86.
Zaino, R. J., Kurman, R. J., Brunetto, V. L., Morrow, C. P., Bentley, R. C., Cappellari, J. O., & Bitterman, P. (1998). Villoglandular adenocarcinoma of the endometriu: A clinicopathologic study of 61 cases: A gynecology oncology study. The American Journal of Surgical Pathology, 22(11), 1379–1385.
Zaloudek, C., Hayashi, G. M., Ryan, I. P., Powell, C. B., & Miller, T. R. (1997). Microglandular adenocarcinoma of the endometrium: A form of mucinous adenocarcinoma that may be confused with microgalnadular hyperplasia of the cervix. International Journal of Gynecological Pathology, 16(1), 52–59.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Husain, S. (2022). Epithelial Tumors and Precursors, Type 1. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_5624-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28845-1_5624-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28845-1
Online ISBN: 978-3-319-28845-1
eBook Packages: Springer Reference MedicineReference Module Medicine